ATE538198T1 - Elongasegene und deren verwendungen - Google Patents

Elongasegene und deren verwendungen

Info

Publication number: ATE538198T1
Authority: AT; Austria
Prior art keywords: acid; fatty acids; docosapentaenoic; dgla; epa
Prior art date: 2002-05-29

Application number

AT03756242T

Other languages

English (en)

Inventor

Pradip Mukerji

Amanda LEONARD

Yung-Sheng Huang

Suzette Pereira

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2003-05-29

Publication date

2012-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29709610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE538198(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-05-29 Application filed by Abbott Lab filed Critical Abbott Lab

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE538198T1 publication Critical patent/ATE538198T1/de

Links

108090000623 proteins and genes Proteins 0.000 title abstract 3
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 6
TWSWSIQAPQLDBP-CGRWFSSPSA-N (7e,10e,13e,16e)-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O TWSWSIQAPQLDBP-CGRWFSSPSA-N 0.000 abstract 3
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 3
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 3
235000021292 Docosatetraenoic acid Nutrition 0.000 abstract 3
TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 abstract 3
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 3
235000021342 arachidonic acid Nutrition 0.000 abstract 3
229940114079 arachidonic acid Drugs 0.000 abstract 3
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 3
235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 3
229960005135 eicosapentaenoic acid Drugs 0.000 abstract 3
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 3
238000006243 chemical reaction Methods 0.000 abstract 2
235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000021281 monounsaturated fatty acids Nutrition 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Hematology (AREA)
Polymers & Plastics (AREA)
Birds (AREA)
Food Science & Technology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)

AT03756242T 2002-05-29 2003-05-29 Elongasegene und deren verwendungen ATE538198T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/156,911 US20030163845A1 (en)	1998-09-02	2002-05-29	Elongase genes and uses thereof
PCT/US2003/016863 WO2003102138A2 (en)	2002-05-29	2003-05-29	Elongase genes and uses thereof

Publications (1)

Publication Number	Publication Date
ATE538198T1 true ATE538198T1 (de)	2012-01-15

Family

ID=29709610

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03756242T ATE538198T1 (de)	2002-05-29	2003-05-29	Elongasegene und deren verwendungen

Country Status (10)

Country	Link
US (3)	US20030163845A1 (de)
EP (1)	EP1507855B2 (de)
JP (1)	JP4434944B2 (de)
AT (1)	ATE538198T1 (de)
AU (1)	AU2003243335B2 (de)
BR (1)	BR0306655A (de)
CA (1)	CA2487095C (de)
ES (1)	ES2376225T5 (de)
MX (1)	MXPA04011902A (de)
WO (1)	WO2003102138A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11952581B2 (en)	2003-08-01	2024-04-09	Basf Plant Science Gmbh	Process for the production of polyunsaturated fatty acids in transgenic organisms
EP2166070B1 (de)	2003-08-01	2015-09-16	BASF Plant Science GmbH	Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenen Organismen
CN1930277B (zh)	2004-02-27	2011-02-02	巴斯福植物科学有限公司	在转基因植物中产生多不饱和脂肪酸的方法
US7777098B2 (en)	2004-02-27	2010-08-17	Basf Plant Science Gmbh	Method for producing unsaturated ω-3-fatty acids in transgenic organisms
ES2529572T3 (es)	2004-04-22	2015-02-23	Commonwealth Scientific And Industrial Research Organisation	Síntesis de ácidos grasos poliinsaturados de cadena larga por células recombinantes
EP2363492A3 (de)	2004-04-22	2012-03-14	Commonwealth Scientific and Industrial Research Organisation	Synthese von langkettigen polyungesättigten Fettsäuren durch rekombinante Zellen
BRPI0511236A (pt)	2004-06-04	2007-11-27	Fluxome Sciences As	método para a produção de ácidos graxos poliinsaturados com quatro ou mais ligações duplas, saccharomyces cerevisiae geneticamente modificado que tem capacidade de produzir ácidos graxos poliinsaturados com quatro ou mais ligações duplas quando desenvolvido em um substrato que não de ácido graxo, composição, uso da composição e uso de um saccharomyces cervisiae geneticamente modificado
US8431165B2 (en) *	2004-12-13	2013-04-30	Swing Aerobics Licensing, Inc.	Medicament for treatment of cancer and other diseases
US8092839B2 (en) *	2004-12-13	2012-01-10	Swing Aerobics Licensing, Inc.	Medicament for treatment of cancer and other diseases
JP5181486B2 (ja) *	2006-02-16	2013-04-10	大正製薬株式会社	亜鉛化合物配合経口用組成物
AR059376A1 (es)	2006-02-21	2008-03-26	Basf Plant Science Gmbh	Procedimiento para la produccion de acidos grasos poliinsaturados
US8816106B2 (en)	2006-08-29	2014-08-26	Commonwealth Scientific And Industrial Research Organisation	Synthesis of fatty acids
KR20100031528A (ko)	2007-06-01	2010-03-22	더 트러스티즈 오브 프린스턴 유니버시티	숙주세포 대사경로의 조절을 통한 바이러스 감염 치료
US7892792B2 (en)	2008-06-27	2011-02-22	Indian Institute Of Science	Cells expressing Pichia cytochrome C
CN113957054B (zh)	2008-11-18	2024-07-16	联邦科学技术研究组织	产生ω-3脂肪酸的酶和方法
RU2556375C1 (ru) *	2011-08-04	2015-07-10	Сантори Холдингз Лимитед	Белок, обладающий активностью в отношении стимуляции элонгации цепей жирных кислот, кодирующий его ген и их применение
SG10201810439SA (en)	2012-06-15	2018-12-28	Commw Scient Ind Res Org	Production of long chain polyunsaturated fatty acids in plant cells
CN105189744B (zh) *	2013-03-27	2018-09-18	三得利控股株式会社	在被孢霉属微生物内显示高表达活性的启动子
CA2933909C (en)	2013-12-18	2024-07-02	Commonwealth Scientific And Industrial Research Organisation	Lipid comprising long chain polyunsaturated fatty acids
EP3160482A4 (de)	2014-06-27	2018-02-14	Commonwealth Scientific and Industrial Research Organisation	Lipid mit docosapentensäure
CN110373436B (zh) *	2018-12-11	2022-09-23	山东理工大学	一种产双高-γ-亚麻酸卷枝毛霉细胞工厂的构建方法及发酵技术
CN110923261B (zh) *	2019-12-20	2021-12-17	江南大学	一种提高酿酒酵母细胞膜脂肪酸c20:0和/或c22:0含量的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4943674A (en) *	1987-05-26	1990-07-24	Calgene, Inc.	Fruit specific transcriptional factors
US5420034A (en) *	1986-07-31	1995-05-30	Calgene, Inc.	Seed-specific transcriptional regulation
GB8507058D0 (en) *	1985-03-19	1985-04-24	Efamol Ltd	Pharmaceutical & dietary compositions
GB8524276D0 (en) *	1985-10-02	1985-11-06	Efamol Ltd	Pharmaceutical & dietary compositions
GB8524275D0 (en) *	1985-10-02	1985-11-06	Efamol Ltd	Pharmaceutical & dietary compositions
US5188958A (en) *	1986-05-29	1993-02-23	Calgene, Inc.	Transformation and foreign gene expression in brassica species
WO1988007577A1 (en)	1987-03-31	1988-10-06	Schering Biotech Corporation	Glycosylation inhibiting factors
GB8714772D0 (en)	1987-06-24	1987-07-29	Efamol Ltd	Essential fatty acid compositions
IE63225B1 (en) *	1988-09-13	1995-04-05	Efamol Holdings	Use of fatty acids in the treatment of myalgic encephalomyelitis
US5106739A (en) *	1989-04-18	1992-04-21	Calgene, Inc.	CaMv 355 enhanced mannopine synthase promoter and method for using same
US5196198A (en) *	1989-06-02	1993-03-23	Abbott Laboratories	Parenteral nutrition product
FR2648347B1 (fr)	1989-06-15	1994-04-29	Sederma Sa	Preparations cosmetiques possedant des proprietes adoucissantes
US5175095A (en) *	1989-07-19	1992-12-29	Calgene, Inc.	Ovary-tissue transcriptional factors
DE69103753T3 (de) *	1990-05-25	2008-01-24	E.I. Dupont De Nemours And Co., Wilmington	Nukleotidsequenz des gens für stearoyl-acp-desaturase aus soja.
PH31293A (en) *	1991-10-10	1998-07-06	Rhone Poulenc Agrochimie	Production of y-linolenic acid by a delta6-desaturage.
DK0616644T3 (da)	1991-12-04	2003-10-27	Du Pont	Fedtsyredesaturase-gener fra planter
DE69333025T2 (de)	1992-11-17	2004-04-29	E.I. Du Pont De Nemours And Co., Wilmington	Für mikrosom delta 12 fettsäuredesaturase kodierende gene und verwandte enzyme von pflanzen
ES2148323T3 (es) *	1993-02-26	2000-10-16	Calgene Llc	Sistema de expresion de un gen a base de geminivirus.
NZ281041A (en) *	1994-03-09	1998-04-27	Abbott Lab	Non-human mammals transformed with a catalytic entity of enzymes or antibodies to produce a heterologous product in the animals milk
US5750176A (en) *	1994-03-09	1998-05-12	Abbott Laboratories	Transgenic non-human mammal milk comprising 2'-fucosyl-lactose
NZ279676A (en)	1994-03-09	1998-04-27	Abbott Lab	Humanized milk produced by non-human transgenic mammal transformed with a heterologous gene coding for human enzyme producing human oligosaccharides and glycoconjugates
US5484724A (en) *	1994-05-26	1996-01-16	Merck & Co., Inc.	DNA encoding GLSI
US5545553A (en) *	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5654402A (en)	1994-10-26	1997-08-05	Michigan State University	Methods and compositions relating to plant Δ6 palmitoyl-acyl carrier protein desaturase
WO1998039448A2 (en)	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 human secreted proteins
US5972664A (en)	1997-04-11	1999-10-26	Abbott Laboratories	Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US6677145B2 (en) *	1998-09-02	2004-01-13	Abbott Laboratories	Elongase genes and uses thereof
US6403349B1 (en)	1998-09-02	2002-06-11	Abbott Laboratories	Elongase gene and uses thereof
WO2000070945A2 (en)	1999-05-20	2000-11-30	Karolinska Innovations Ab	Fatty acid elongation genes and uses thereof
EP1254238B1 (de)	2000-02-09	2009-09-16	Basf Se	Neues elongasegen und verfahren zur herstellung mehrfach ungesättigter fettsäuren

2002
- 2002-05-29 US US10/156,911 patent/US20030163845A1/en not_active Abandoned
2003
- 2003-05-29 AU AU2003243335A patent/AU2003243335B2/en not_active Ceased
- 2003-05-29 AT AT03756242T patent/ATE538198T1/de active
- 2003-05-29 MX MXPA04011902A patent/MXPA04011902A/es active IP Right Grant
- 2003-05-29 WO PCT/US2003/016863 patent/WO2003102138A2/en not_active Ceased
- 2003-05-29 ES ES03756242.8T patent/ES2376225T5/es not_active Expired - Lifetime
- 2003-05-29 JP JP2004510380A patent/JP4434944B2/ja not_active Expired - Fee Related
- 2003-05-29 BR BR0306655-0A patent/BR0306655A/pt active Search and Examination
- 2003-05-29 EP EP03756242.8A patent/EP1507855B2/de not_active Expired - Lifetime
- 2003-05-29 CA CA2487095A patent/CA2487095C/en not_active Expired - Fee Related
2004
- 2004-08-05 US US10/912,446 patent/US7375205B2/en not_active Expired - Fee Related
2008
- 2008-03-12 US US12/046,857 patent/US7968692B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MXPA04011902A (es)	2005-03-31
ES2376225T5 (es)	2015-01-12
AU2003243335A1 (en)	2003-12-19
US20050009140A1 (en)	2005-01-13
JP2005527238A (ja)	2005-09-15
EP1507855B2 (de)	2014-12-03
EP1507855A4 (de)	2006-06-21
US7968692B2 (en)	2011-06-28
JP4434944B2 (ja)	2010-03-17
BR0306655A (pt)	2005-05-10
WO2003102138A3 (en)	2004-06-17
EP1507855A2 (de)	2005-02-23
CA2487095A1 (en)	2003-12-11
US7375205B2 (en)	2008-05-20
US20030163845A1 (en)	2003-08-28
ES2376225T3 (es)	2012-03-12
AU2003243335B2 (en)	2008-07-17
US20080176944A1 (en)	2008-07-24
WO2003102138A2 (en)	2003-12-11
EP1507855B1 (de)	2011-12-21
CA2487095C (en)	2011-08-16

Publication	Publication Date	Title
ATE538198T1 (de)	2012-01-15	Elongasegene und deren verwendungen
MXPA03000750A (es)	2004-03-18	Genes de elongasa y usos de los mismos.
WO2000012720A3 (en)	2000-09-08	Elongase genes and uses thereof
EP1401259A4 (de)	2005-06-22	-4-desaturase-gene und ihre verwendung
MXPA03006663A (es)	2004-05-31	Genes de desaturasa y usos de los mismos.
AR022224A1 (es)	2002-09-04	Gen de la desaturasa humana y usos del mismo
DK1480993T4 (da)	2012-08-13	Desaturasegener, enzymer kodet heraf og anvendelser heraf
EP2402448A3 (de)	2012-04-25	Herstellung mehrfach ungesättigter Fettsäuren in ölhaltigen Hefen
WO2007136646A3 (en)	2008-03-20	Delta5 desaturase and its use in making polyunsaturated fatty acids
ATE542892T1 (de)	2012-02-15	Delta-17-desaturasen und ihre verwendung bei der herstellung von mehrfach ungesättigten fettsäuren
BR0311324A (pt)	2005-06-28	Dessaturases de ácidos graxos de fungos
MXPA05005777A (es)	2006-03-08	Metodo novedoso para produccion de acidos grasos poliinsaturados.
DE69937050D1 (de)	2007-10-18	Polyungesättigte fettsäuren in pflanzen
EP2357243A3 (de)	2011-11-23	Synthese von langkettigen polyungesättigten Fettsäuren durch rekombinante Zellen
ATE456645T1 (de)	2010-02-15	Funktionelle acylglyceride
NO20043592L (no)	2004-10-29	Nytt elongasegen og fremgangsmate for fremstilling av flerumettede fettsyrer
WO2008064096A3 (en)	2008-10-09	Elongase gene and uses thereof
UA105482C2 (uk)	2014-05-26	Соняшник з низьким вмістом насичених жирів
NO20071180L (no)	2007-05-31	Delta 6-desaturase-gener og anvendelser derav
WO2008073275A3 (en)	2008-08-07	Mutant delta-8 desaturase genes engineered by targeted mutagensis and their use in making polyunsaturated fatty acids
Ouyang et al.	2016	Resources and bioactivities of polyunsaturated fatty acids
AR039898A1 (es)	2005-03-09	Genes de elongasas y usos de los mismos
Shen et al.	2009	Drosophila lacks C20 and C22 polyunsaturated fatty acids